Literature DB >> 26520007

Selective management strategy of interrupted aortic arch mitigates left ventricular outflow tract obstruction risk.

Bahaaldin Alsoufi1, Brian Schlosser2, Courtney McCracken2, Ritu Sachdeva2, Brian Kogon3, William Border2, William T Mahle2, Kirk Kanter3.   

Abstract

BACKGROUND: Left ventricular outflow tract obstruction (LVOTO) is an important problem after interrupted aortic arch (IAA) repair, especially when early reoperation is required during infancy. Several anatomic factors have been identified that increase LVOTO risk; surgical strategies such as concomitant resection of the conal septum or left ventricular outflow tract (LVOT) bypass (single-stage Yasui operation, or staged Norwood procedure, followed by the Rastelli procedure) have been proposed for such patients.
METHODS: From 2002 to 2013, a total of 77 neonates underwent IAA repair. Based on the presence of anatomic substrate for LVOTO, patients underwent standard IAA repair and ventricular septal defect closure (n = 53; 69%), concomitant conal resection (n = 7; 9%), or LVOT bypass (n = 17; 22%, staged in 14). We analyzed anatomic details that influence procedure choice, and explored reoperation risk and survival after repair.
RESULTS: Neonates who had conal resection or LVOT bypass had significantly smaller aortic valve and subaortic areas, as well as a trend toward a higher prevalence of type B IAA, aberrant right subclavian artery, and bicuspid aortic valve. Freedom from LVOT reoperation was 96% and 80%, at 1 and 8 years, respectively, and was lower after conal resection (P = .008). Most LVOT reoperations (73%) were for discrete subaortic obstruction. Survival was 86% at 8 years, and was not related to procedure choice, whereas freedom from all-cause reoperation was 65% at 8 years, and was higher after standard repair (P = .029).
CONCLUSIONS: Compared with published reports, this selective management strategy, which is customized to the degree of aortic valve and subaortic area narrowing, has mitigated and delayed LVOTO risk. With this tailored approach, most LVOT reoperations occur after infancy and are commonly for discrete subaortic obstruction. The effect of aortic valve and LVOT narrowing on increased LVOTO risk is neutralized with LVOT bypass procedures; however, it continues to be the highest after conal resection, suggesting the superiority of LVOT bypass, compared with enlargement in neonates who are at risk of developing LVOTO.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  interrupted aortic arch; left ventricular outflow tract obstruction

Mesh:

Year:  2015        PMID: 26520007     DOI: 10.1016/j.jtcvs.2015.09.060

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

Review 1.  Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers.

Authors:  Marta Unolt; Paolo Versacci; Silvia Anaclerio; Caterina Lambiase; Giulio Calcagni; Matteo Trezzi; Adriano Carotti; Terrence Blaine Crowley; Elaine H Zackai; Elizabeth Goldmuntz; James William Gaynor; Maria Cristina Digilio; Donna M McDonald-McGinn; Bruno Marino
Journal:  Am J Med Genet A       Date:  2018-04-16       Impact factor: 2.802

Review 2.  A review of the Yasui operation with long-term follow-up of a case.

Authors:  Ajaykumar R Pandey; Sibashankar Kar; Neeraj Aggarwal; Salil Bhargava; Reena Khantwal Joshi; Raja Joshi
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-08-03

3.  Outcomes Following Aortic Valve Replacement in Children With Conotruncal Anomalies.

Authors:  Bahaaldin Alsoufi; Jessica H Knight; James St Louis; Geetha Raghuveer; Lazaros Kochilas
Journal:  World J Pediatr Congenit Heart Surg       Date:  2022-03

Review 4.  Aortic Atresia or Complex Left Outflow Tract Obstruction in the Presence of a Ventricular Septal Defect.

Authors:  Allison J Howell; Madison B Argo; David J Barron
Journal:  World J Pediatr Congenit Heart Surg       Date:  2022-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.